Peripheral stenting technologies encompass all vasculature but coronary. We have assessed the volume of all such peripheral stenting procedures through 2020 worldwide.
Peripheral stenting procedures include lower extremity bare metal and drug-eluting stents for treatment of symptomatic periperal artery disease (PAD) and critical limb ischemia resulting from iliac, femoropopliteal and infrapopliteal occlusive disease; stent-grafting devices used in endovascular repair of abdominal and thoracic aortic aneurysms; as well as a subset of indication-specific and multipurpose peripheral stents used in recanalization of iliofemoral and iliocaval occlusions resulting in chronic venous insufficiency.
In 2015, these peripheral stenting systems were employed in approximately 1.565 million revascularization procedures worldwide, of which the lower extremity arterial stenting accounted for over 80%, followed by abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA) endovascular repairs and peripheral venous stenting.
Below is illustrated the top geographic areas by caseload for individual peripheral stenting technologies.
Source: MedMarket Diligence, LLC, “Global Market Opportunities in Peripheral Arterial and Venous Stents, Forecast to 2020”, Report #V201.
Below is illustrated, in order, the top growth areas geographically in peripheral stenting for the period 2015 to 2020. Note that the subtotal of all peripheral stenting products for Asia-Pacific falls within this listing of the top areas of growth in peripheral stenting.
Source: Report #V201.